Mohamed A Kharfan-Dabaja Selected Research

Mohamed A Kharfan-Dabaja Research Topics

Disease

35	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 05/2006
27	Neoplasms (Cancer) 10/2022 - 02/2005
24	Lymphoma (Lymphomas) 01/2022 - 03/2005
19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2022 - 10/2010
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 04/2007
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 09/2008
15	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2006
14	B-Cell Lymphoma (Lymphoma, B Cell) 07/2022 - 07/2013
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 03/2011
13	Leukemia 02/2022 - 08/2003
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2013
11	Multiple Myeloma 01/2022 - 10/2006
8	Bronchiolitis Obliterans Syndrome 11/2022 - 09/2009
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2022 - 04/2009
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 11/2016
7	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2012
6	Infections 01/2022 - 01/2013
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2022 - 07/2013
5	Plasma Cell Leukemia 07/2021 - 12/2011
4	Cytokine Release Syndrome 01/2022 - 01/2019
4	Hypoalbuminemia 07/2021 - 03/2011
4	Pathologic Complete Response 01/2020 - 05/2015
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 11/2017
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 10/2010
3	Hodgkin Disease (Hodgkin's Disease) 06/2021 - 11/2017
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Lymphopenia (Lymphocytopenia) 10/2022 - 09/2013
2	Thrombocytopenia (Thrombopenia) 10/2022 - 08/2004
2	Cytopenia 10/2022 - 09/2013
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2022 - 10/2020
2	Viremia 01/2022 - 03/2015
2	Thrombosis (Thrombus) 01/2022 - 08/2004
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2018
2	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 11/2010
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020 - 01/2019
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2018 - 09/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2017 - 05/2016
2	Disease Progression 01/2016 - 09/2008
2	Myocardial Infarction 05/2015 - 08/2004
1	Neutropenia 10/2022
1	Anemia 10/2022
1	cell-associated neurotoxicity 01/2022
1	Residual Neoplasm 01/2022
1	Herpesviridae Infections (Herpesvirus Infection) 01/2022
1	Immunoproliferative Small Intestinal Disease 01/2022

Drug/Important Bio-Agent (IBA)

20	Chimeric Antigen ReceptorsIBA 10/2022 - 01/2019
14	Rituximab (Mabthera)FDA Link 10/2022 - 09/2009
11	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 05/2010
9	Busulfan (Busulfex)FDA Link 11/2021 - 10/2010
8	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 07/2010
7	AntigensIBA 02/2022 - 02/2005
7	axicabtagene ciloleucelIBA 01/2022 - 01/2019
7	fludarabineIBA 11/2021 - 02/2011
6	Calcineurin InhibitorsIBA 01/2022 - 02/2016
6	Sirolimus (Rapamycin)FDA Link 01/2018 - 05/2010
5	Tyrosine Kinase InhibitorsIBA 03/2022 - 09/2008
5	Monoclonal AntibodiesIBA 01/2016 - 12/2006
4	GlucocorticoidsIBA 11/2022 - 10/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 02/2016
4	Lenalidomide (CC 5013)FDA Link 04/2022 - 01/2016
4	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 06/2012
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2016
4	tisagenlecleucelIBA 12/2019 - 01/2019
4	Biological ProductsIBA 11/2017 - 10/2006
4	VaccinesIBA 09/2013 - 08/2003
3	ofatumumab FDA Link 11/2022 - 07/2013
3	SteroidsIBA 11/2021 - 09/2009
3	Serum AlbuminIBA 07/2021 - 03/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 07/2010
3	Pharmaceutical PreparationsIBA 12/2019 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 05/2015
2	C-Reactive ProteinIBA 06/2022 - 06/2021
2	obinutuzumabIBA 04/2022 - 01/2019
2	Ferritins (Ferritin)IBA 06/2021 - 05/2006
2	Alemtuzumab (Campath)FDA Link 01/2020 - 09/2013
2	ibrutinibIBA 01/2018 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 05/2016 - 05/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2016 - 07/2013
2	Bortezomib (Velcade)FDA Link 09/2015 - 06/2012
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 02/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 07/2013
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	fibrin fragment D (D-dimer)IBA 06/2022

Therapy/Procedure

112	Cell Transplantation 11/2022 - 04/2007
71	Therapeutics 11/2022 - 03/2005
35	Transplantation 01/2022 - 04/2009
18	Homologous Transplantation 01/2022 - 10/2010
14	Drug Therapy (Chemotherapy) 01/2022 - 08/2009
12	Hematopoietic Stem Cell Transplantation 01/2022 - 05/2006
8	Immunotherapy 04/2022 - 09/2013
6	Autologous Transplantation 02/2022 - 09/2013
2	Artificial Respiration (Mechanical Ventilation) 06/2022 - 01/2010
2	Radiotherapy 01/2022 - 01/2020
2	Haploidentical Transplantation 01/2022 - 06/2018
2	Salvage Therapy 01/2022 - 01/2016
2	Photopheresis 10/2017 - 11/2014
2	Radioimmunotherapy 09/2013 - 12/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2013 - 01/2010
1	Aftercare (After-Treatment) 04/2022
1	Donor Selection 03/2022